02212018Headline:

New York, New York

HomeNew YorkNew York

Roopal Luhana

JPML Orders Transfer of Onglyza Lawsuits to Eastern District of Kentucky

On February 2, 2018, the U.S. Judicial Panel on Multidistrict Litigation (“JPML” or “panel”) ordered that all federally-filed Onglyza (saxagliptin) lawsuits be centralized in the Eastern District of Kentucky.  That means a total of 84 cases pending in over 26 […]

Roopal Luhana

FDA Warns Customers to Stop Taking Limbrel for Arthritis

On December 5, 2017, the FDA released a safety advisory notifying doctors and patients of potential health hazards associated with Limbrel capsules. Limbrel was approved as a “medical food” that is intended to help manage the inflammation associated with osteoarthritis. […]

Roopal Luhana

Study Links E-Cigarettes to Birth Defects

So-called “popcorn lung” is a serious lung disease that causes inflammation and scarring in the airways and eventually leads to permanent lung damage. The disease was so-named because back in the 1990s, an abnormally large number of microwave popcorn factory […]

Eric T. Chaffin

Will the JPML Approve Consolidation of Onglyza Lawsuits?

If you’ve filed an Onglyza lawsuit, or if you’re thinking about it, mark January 25, 2018 on your calendar. That is the day that the U.S. Judicial Panel on Multidistrict Litigation will be hearing arguments about whether to consolidate all […]

Roopal Luhana

J&J Seeking to Expand Use of Xarelto Despite Side Effects

More than 20,500 Xarelto lawsuits are pending in consolidated litigation in the U.S. District Court for the Eastern District of Louisiana, and another 1,400 are pending in a mass tort in Philadelphia. Plaintiffs claim that after taking the blood-thinning medication, […]

Roopal Luhana

AndroGel and Axiron Trials Scheduled for January

In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed testosterone replacement lawsuits into one court in the Northern District of Illinois. District Court Judge Matthew Kennelly is overseeing the pre-trial proceedings. The lawsuits before Judge […]

Eric T. Chaffin

Plaintiffs Seek Consolidation of Onglyza Lawsuits

Back in July 2009, the FDA approved the new drug Onglyza (saxagliptin) for the treatment of type 2 diabetes. In 2014, however, they issued a drug safety communication stating that they had requested additional clinical trial data from the manufacturers, […]

Kendra Goldhirsch

Studies Say No Difference in Safety Between Xarelto and Warfarin

In a new study published by the British Medical Journal (BMJ), researchers reported that so-called “new-generation” blood thinners like Xarelto and Eliquis were no safer when it came to the risk of excessive bleeding than warfarin, the leading blood thinner […]

Kendra Goldhirsch

Georgia Man Blames Onglyza for Heart Failure

On October 25, 2017, a Georgia man filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca Pharmaceuticals, in the U.S. District Court for the Middle District of Georgia. He claims that after taking Onglyza, which is a type […]

Roopal Luhana

Mississippi Woman Seeks Xarelto Retrial on the Basis of New Evidence

In August 2017, the third Xarelto bellwether trial concluded in the U.S. District Court in Jackson, Mississippi. The jury sided with the drug manufacturers, Bayer and Johnson & Johnson. This was the third win for the defense in the consolidated […]